Full CoverageTop news
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies
By Thomas P Peacock, David L Robertson & Emma C Thomson
Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
By Benjamin Israelow, Akiko Iwasaki & Huiping Dong
Clinical & Translational Immunology | ASI Journal
Evolution of naturally arising SARS-CoV-2 defective interfering particles | Communications Biology
By Matthias Gotte, Tom Hobman & Jerry Pelletier
All coverage
Host protein kinases required for SARS-CoV-2 nucleocapsid phosphorylation and viral replication
By Benjamin R tenOever, Jared L Johnson & Benjamin E Nilsson
Detection and prevalence of SARS-CoV-2 co-infections during the Omicron variant circulation in France
By Florence Morfin, Laurence Josset & Antonin Bal
SARS-CoV-2 Omicron variant is attenuated for replication in a polarized human lung epithelial cell model
By Michael Laue, Djin-Ye Oh & Daniel R Bourquain
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
By Hana Golding, Juanjie Tang & Ralph S. Baric
Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial
By Ruian Ke, Carlee B Moser & Paul Klekotka